Statistics for SpringWorks Therapeutics (id:7677 SWTX)

Valuation metrics

Market cap

2.71B

Enterprise value

2.34B

Trailing P/E (ttm)

-7.58

Forward P/E

-17.03

PEG ratio

-17.03

Price/Sales (ttm)

20.01

Price/Book (mrq)

5.09

Enterprise Value/Revenue

17.28

Enterprise Value/EBITDA

-8.01

Overview

Shares outstanding

74.39M

Float

72.91M

Shares short

11.63M

% Held by insiders

0.02%

% Held by institutions

1.17%

Average volume (10 days)

1.89M

Average volume (90 days)

Price summary

52-Week low

20.19

52-Week high

53.92

52-Week change

46.77%

Beta

0.79

50-Day moving average

32.70

200-Day moving average

40.17

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-203.09%

Operating margin

-117.52%

Operational effectiveness

Return on assets

-34.28%

Return on equity

-59.33%

Income statement

Revenue (ttm)

1.88

Revenue per share (ttm)

1.88

Quarterly revenue growth (yoy)

Gross profit (ttm)

5.02M

EBITDA

-292,263,008.00

Net income to common (ttm)

-275,156,000.00

Diluted EPS (ttm)

-3.89

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

376.62M

Total cash per share (mrq)

5.06

Total debt (mrq)

6.91M

Total Debt/Equity (mrq)

1.30

Current ratio (mrq)

616.20%

Book value per share (mrq)

7.17

Cash flow

Cash flow statement

-208,804,000.00

Levered free cash flow (LFCF)

-114,416,496.00